The extent to which individuals with a variety of cultural backgrounds differ in empathic responsiveness is unknown. This article describes the differences in trait empathy in one independent and one interdependent society (i.e., the US and Iran, respectively). The analysis of data collected from self-reported questionnaires answered by 326 adults indicated a significant difference in the cognitive component of empathy concerning participants’ affiliation to either egocentric or socio-centric society: Iranian participants with interdependent cultural norms, reported higher cognitive empathy compared to (...) American participants who share independent cultural norms. In line with previous studies, gender differences were observed in all subscales of questionnaires, except the Empathy Quotient (EQ). Female participants demonstrated more empathy than males in both samples. Implications for understanding the cross-cultural differences of various components of empathy are discussed. (shrink)

The article examines the challenges involved in the process of developing artificial ethical agents. The process involves the creators or designing professionals, the procedures to develop an ethical agent and the artificial systems. There are two possibilities available to create artificial ethical agents: (a) programming ethical guidance in the artificial Intelligence (AI)-equipped machines and/or (b) allowing AI-equipped machines to learn ethical decision-making by observing humans. However, it is difficult to fulfil these possibilities due to the subjective nature of ethical decision-making. (...) The challenge related to the developers is that they themselves lack training in ethical skills. The creators who develop an artificial ethical agent should be able to foresee the ethical issues and have knowledge about ethical decision-making to improve the ethical use of AI-equipped machines. The suggestion is that the focus should be on training professionals involved in the process of developing these artificial systems in ethics rather than developing artificial ethical agents and thereby attributing ethical agency to it. (shrink)

The article examines the challenges involved in the process of developing artificial ethical agents. The process involves the creators or designing professionals, the procedures to develop an ethical agent and the artificial systems. There are two possibilities available to create artificial ethical agents: (a) programming ethical guidance in the artificial Intelligence (AI)-equipped machines and/or (b) allowing AI-equipped machines to learn ethical decision-making by observing humans. However, it is difficult to fulfil these possibilities due to the subjective nature of ethical decision-making. (...) The challenge related to the developers is that they themselves lack training in ethical skills. The creators who develop an artificial ethical agent should be able to foresee the ethical issues and have knowledge about ethical decision-making to improve the ethical use of AI-equipped machines. The suggestion is that the focus should be on training professionals involved in the process of developing these artificial systems in ethics rather than developing artificial ethical agents and thereby attributing ethical agency to it. (shrink)

This dissertation is a collection of four studies which collectively explore a hypothesized construct of ‘moral evaluation of patient behaviors’ (MEPB) as a driver of health professionals’ readiness to interact humanistically with their patients. In these studies, ‘humanistic interactions’ refer to the non-technical, intangible skills and factors of clinical competence; the factors specifically explored in these studies were compassion toward patients, self-efficacy for treating patients, and optimism toward patient treatment. For the purpose of specificity, all factors were examined as they (...) pertained to patients with substance use disorders. Survey data from a convenience sample of 524 health professionals (i.e. physicians, nurses, and other health professionals) from three culturally distinct areas of the world (i.e. California (n = 173), urban France (n = 102), and urban China (n = 249)) were analyzed using analyses of variance, Welch’s t-tests, confirmatory factor analyses, and structural equation models. Results indicate: 1.) Psychometric support for the survey tool that was created for the assessment of the hypothesized construct of MEPB among health professionals, and information on differences on this hypothesized construct by age group, occupation, and country of residence; 2.) Indication that this survey tool operates differently among health professionals in different countries, which supports the notion that people from differing cultures have differing notions about morality. 3.) In the California sample, results indicate that while moral judgements of patients’ behavior carries mixed associations with factors of health professionals’ readiness to interact humanistically with these patients, moral judgements of the self (or, moral self-image) have only positive associations with factors of this readiness for humanistic interaction. This finding supports the notion that having a healthy self-concept strengthens one’s ability to support others. 4.) In all three countries, moral evaluations were positively associated with optimism toward treating patients, and in urban China, they were additionally positively associated with compassion and with self-efficacy. Given weak measurement invariance (i.e. differences in the operation of the measurement of moral evaluations by country), more research is needed in this area. The current research provides a tool for examining research of just this nature, and most importantly suggests that morality does not need to be eliminated from perspectives of mental illness or addiction, but rather that more nuanced moral perspectives are needed. Future research may explore distinctions between moral appraisals and stigma, and associations between moral evaluations (both among health professionals and among patients) and clinical/health outcomes such as rates of relapse and recovery. (shrink)